Detalhe da pesquisa
1.
Randomized phase 2 trial of tremelimumab and durvalumab in combination versus sequentially in recurrent platinum-resistant ovarian cancer.
Cancer;
130(7): 1061-1071, 2024 04 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38009662
2.
Data Acquisition and Intraoperative Tissue Analysis on a Mobile, Battery-Operated, Orbitrap Mass Spectrometer.
Anal Chem;
2024 May 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38739527
3.
Detection of Residual Peritoneal Metastases Following Cytoreductive Surgery Using Pegsitacianine, a pH-Sensitive Imaging Agent: Final Results from a Phase II Study.
Ann Surg Oncol;
2024 Apr 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38622456
4.
Efficacy, safety, and feasibility of Apixaban for postoperative venous thromboembolism prophylaxis following open gynecologic cancer surgery at a comprehensive cancer center.
Gynecol Oncol;
2024 Feb 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38368180
5.
Clinical implications of tumor-based next-generation sequencing in high-grade epithelial ovarian cancer.
Cancer;
129(11): 1672-1680, 2023 06 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36930815
6.
Characterizing morphologic subtypes of high-grade serous ovarian cancer by CT: a retrospective cohort study.
Int J Gynecol Cancer;
33(6): 937-943, 2023 06 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36948527
7.
Hormone receptor status and the role of oophorectomy in uterine leiomyosarcoma.
Gynecol Oncol;
167(3): 490-495, 2022 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36270831
8.
Frailty repels the knife: The impact of frailty index on surgical intervention and outcomes.
Gynecol Oncol;
166(1): 50-56, 2022 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35599168
9.
Clinical analysis of pathologic complete responders in advanced-stage ovarian cancer.
Gynecol Oncol;
165(1): 82-89, 2022 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35216808
10.
Association between time to diagnosis, time to treatment, and ovarian cancer survival in the United States.
Int J Gynecol Cancer;
32(9): 1153-1163, 2022 09 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36166208
11.
Timing of surgery in patients with partial response or stable disease after neoadjuvant chemotherapy for advanced ovarian cancer.
Gynecol Oncol;
161(3): 660-667, 2021 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33867146
12.
Toxicity and efficacy of the combination of pembrolizumab with recommended or reduced starting doses of lenvatinib for treatment of recurrent endometrial cancer.
Gynecol Oncol;
162(1): 24-31, 2021 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33958211
13.
Cost-effectiveness of laparoscopic disease assessment in patients with newly diagnosed advanced ovarian cancer.
Gynecol Oncol;
161(1): 56-62, 2021 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33536126
14.
Factors associated with response to neoadjuvant chemotherapy in advanced stage ovarian cancer.
Gynecol Oncol;
162(1): 65-71, 2021 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33838925
15.
Prospective phase II trial of levonorgestrel intrauterine device: nonsurgical approach for complex atypical hyperplasia and early-stage endometrial cancer.
Am J Obstet Gynecol;
224(2): 191.e1-191.e15, 2021 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32805208
16.
Pathologic distribution at the time of interval tumor reductive surgery informs personalized surgery for high-grade ovarian cancer.
Int J Gynecol Cancer;
31(2): 232-237, 2021 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33122243
17.
Correlation of surgeon radiology assessment with laparoscopic disease site scoring in patients with advanced ovarian cancer.
Int J Gynecol Cancer;
31(1): 92-97, 2021 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33154095
18.
The role of neoadjuvant chemotherapy in the management of low-grade serous carcinoma of the ovary and peritoneum: Further evidence of relative chemoresistance.
Gynecol Oncol;
158(3): 653-658, 2020 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32709538
19.
Implementation of a sentinel lymph node mapping algorithm for endometrial cancer: surgical outcomes and hospital charges.
Int J Gynecol Cancer;
30(3): 352-357, 2020 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31911539
20.
ASO Visual Abstract: Detection of Residual Peritoneal Metastases Following Cytoreductive Surgery Using Pegsitacianine, a pH-Sensitive Imaging Agent-Final Results from a Phase 2 Study.
Ann Surg Oncol;
2024 May 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38722420